ABSTRACT
The two cell types typical for Hodgkin disease (HD), namely the mononucleated Hodgkin and the bi-or oligonucleated Reed-Sternberg (RS) cells are very rare in the affected tissues. Thus, since their description in 1832 and 1898, respectively (1, 2) , their lineage derivation and clonality has been a matter of debate. Most analyses of H͞RS cells have been performed by immunohistochemistry (3, 4) . Molecular studies of HD have until recently been restricted to DNA extracted from biopsy specimens and to HD-derived cell lines (5) . The results obtained from these studies were conflicting and did not give a clear picture as to the derivation and clonality of H͞RS cells. This is most likely because of technical problems related to the small number of H͞RS cells in the tissue and to the fact that the origin of the cell lines (except for cell line L1236; refs. 6 and 7) is uncertain. Moreover, no specific pattern of antigens expressed by H͞RS cells allowed to determine the lineage derivation of the cells (8, 9) . H͞RS cells in classical (i.e., nodular sclerosis, mixed cellularity and lymphocyte depletion) HD express CD30 and in most cases CD15 as well as CD25 as surface antigens on a fraction or all of the H͞RS cells, whereas H͞RS cells in lymphocyte predominant HD (HDlp) usually lack expression of these antigens (9, 10) .
That H͞RS cells derive from B lineage cells was clarified by genotypic analyses of single H͞RS cells. Early PCR analyses on single cells derived from HD lymph nodes gave conflicting results (reviewed in ref. 11) . However, other studies demonstrated that H͞RS cells harbor clonal variable regions of Ig heavy chain (V H ) and and light chain (V L ) gene rearrangements and thus represent mature B cells (7, (12) (13) (14) (15) (16) . Furthermore, the pattern of somatic mutations within these rearranged genes identified germinal center B cells as the precursors of H͞RS cells in HD (7, (12) (13) (14) (15) (16) . Besides the lineage derivation of H͞RS cells, their clonality within an affected tissue was also debated. In studies describing that H͞RS cells in HD patients represent a single clone, the cells were micromanipulated from one or several tissue sections of a biopsy specimen (7, (12) (13) (14) (15) (16) . It has been argued that these studies do not rule out the possibility that more than one clone may exist in an affected tissue (17) (18) (19) .
Attempts to isolate H͞RS cells by fluorescence-activated cell sorting have so far been largely unsuccessful, presumably because of the fragility of these very large cells. In one analysis, in which H͞RS cells were reported to be isolated by flow cytometry, no information is given on the purity and viability of the sorted cells (18) . In other analyses describing the isolation of H͞RS cells by density centrifugation, a confirmation that the enriched cells indeed represent H͞RS cells is missing (20) . In another study, single CD3 Ϫ ͞CD20
Ϫ cells with the morphology of H͞RS cells were isolated from cell suspensions by micromanipulation and analyzed for the expression of various genes (21) . Expression of genes of various hematopoietic cell lineages was observed.
Here we describe the isolation of populations of viable H͞RS cells from various human tissues by using high gradient magnetic cell sorting (MACS) that is well suited for the enrichment of rare cell types (22) (23) (24) . Besides the expression of both CD15 and CD30, the morphology of the cells, i.e., their large size and granularity, was taken as a third criterium for their recognition as H͞RS cells. Only from HD-affected tissues cells with this phenotype could be isolated. A molecular analysis of Ig gene rearrangements carried by MACS-enriched CD30 ϩ cells and H͞RS cells micromanipulated from the corresponding HD tissue revealed that the enriched cells indeed represent the H͞RS cells in the tumor.
MATERIALS AND METHODS
Patients and Tissues. Twelve lymph nodes, removed for diagnostic purposes, were analyzed (Table 1) . Three cases were diagnosed as nodular sclerosis HD (HDns), five as mixed cellularity HD (HDmc), one as HDlp and one as ''classical HD, lymphocyte rich'' (HDlr) (10) . Two cases represented activated lymph nodes. From two other patients, presenting with HDns, cells from bone marrow, and from one patient H͞RS cells from pleural and pericardial effusion were analyzed.
Preparation of Cell Suspensions. Lymph nodes were cut into small pieces using scalpels and suspended in RPMI 1640 medium. The resulting cell suspensions were filtered through a 500-m pore mesh. In some cases additional cells were obtained from the remaining tissue pieces by enzymatic digestion. For this purpose, the tissue was incubated with 200 units͞ml collagenase IV (Worthington) and 10 units͞ml DNase I (Promega) for 30 min at 37°C. The cells were then washed in Iscove's modified Dulbecco's medium supplemented with 5% fetal calf serum before filtration as described above and pooled with the other cells.
Cells from pleural and pericardial effusion and from bone marrow were first depleted of erythrocytes in a NH 4 Cl-based buffer (25) . In brief, the cell suspension was diluted 1:1 with RPMI 1640 medium and 4 volumes of the lysing buffer were added. The suspensions were incubated for 15 min on ice before washing twice with PBS͞0.5%BSA. After a final wash, nearly all erythrocytes were depleted.
High-Gradient Magnetic Cell Sorting. For cell sorting the VarioMACS system (Miltenyi Biotec, Auburn, CA) was used. Fragment crystalizable receptors on the cells were blocked by incubation with 2 mg͞ml of Beriglobin (Behring) for 10 min on ice. The cells were then labeled with a mixture of fluoresceinconjugated and unconjugated anti-human CD30 mAbs (BerH2, Dako), for 10 min on ice in PBS͞BSA. After washing, the cells were labeled magnetically with anti-fluorescein isothiocyanate (FITC) Multisort Microbeads (Miltenyi Biotec).
Alternatively, cells were magnetically labeled with CD30 Multisort Microbeads and stained using CD30 Phycoerythrin (both Miltenyi Biotec). The labeled cells selectively bound to a VS column (Miltenyi Biotec) using the VarioMACS and were eluted from the column with 5 ml of PBS͞BSA after removing it from the magnetic field. Efficiency of the separation was controlled by flow cytometry using a FACScan and FACScan Research or Cellquest software (Becton Dickinson). Dead cells were excluded from the analysis by using propidium iodide staining.
Immunophenotyping. Fluorescence-labeled cells enriched by MACS were counterstained with a panel of antibodies conjugated to FITC or Phycoerythrin, with specificity for various human cell surface antigens. The CD15 antibodies were purchased from PharMingen and the CD4, CD8, CD14, CD16, CD19 antibodies from Becton Dickinson. The stains were analyzed by flow cytometry (see above) or by fluorescence microscopy. Some cytospin preparations of enriched cells were stained with the avidin biotin complex method and alkaline phosphatase.
Immunohistochemistry and Micromanipulation. Eight-to 10-m-thick tissue sections and cytospin preparations were stained using mAbs against CD30 (BerH2, Dako), CD20 (L26, Dako), CD15 (LeuM1, Becton Dickinson), or CD3 (OKT3, Ortho Diagnostic). Staining and micromanipulation were performed as described (26, 27) . Bound alkaline phosphatase was visualized by Fast Red (Merck).
Single Cell PCR. Rearranged V genes were amplified from single cells in two rounds of amplification, using three different sets of primers. In the first round of amplification an Expand High Fidelity enzyme mix (Boehringer Mannheim) and in the second round Taq DNA polymerase was used. Variable region genes of heavy chain (V H ) and light chain (V ) were amplified with a collection of V gene family-specific primers hybridizing to sequences within framework region (FR) I of human V H families 1-7 and V families 1-4, together with nested J gene primers, as described (13, 27) . Alternatively, cells were analyzed for V H rearrangements with family-specific V H leader primers together with the same primers for the joining genes of heavy chain (J H ) (14) . In one experiment, six H͞RS cells and the corresponding control samples were analyzed for V H and V gene rearrangements, using the V H FRI and J H The patient data are listed as is the origin of the affected tissues analyzed. Cells positive for CD30 were enriched from lymph nodes (LN) of 10 patients suffering from HD, from two "reactive" lymph nodes, from two HD bone marrow specimens (BM) and from pleural and pericardial effusion of one patient. The frequencies of CD30-positive cells before and after enrichment as determined by flow cytometry are given. Positivity of the enriched cells for CD15 expression was determined either by flow cytometry (fluorescence-activated cell sorter, or FACS) or by immunostaining on cytospins (cyto). The morphology of the sorted cells was determined on cytospins after CD30-specific avidin-biotin-complex staining. ND, not done; HDlr, classical HD, lymphocyte-rich.
primers mentioned above together with primers for eight human V families and J primers (J. Kurth, M.L.H., K.R., and R.K., unpublished data). PCR products were gel-purified and directly sequenced on an Applied Biosystems 377 sequencer (Applied Biosystems).
RESULTS

Magnetic Isolation of CD30-Positive Cells from Different
Tissues. Because CD30 is expressed by H͞RS cells in most if not all cases of classical HD (9) this antigen was chosen as target molecule for the enrichment of H͞RS cells. However, CD30 is expressed also by other populations of hematopoietic cells (28) . We demonstrate below that the large cell size of H͞RS cells and the coexpression of CD30 and CD15 on these cells can be used as reliable criteria to discriminate H͞RS cells from other CD30-positive cells in the isolation procedure.
We first investigated the expression of CD30 on cells from peripheral blood (PB) and lymph nodes of normal donors. The cells were magnetically labeled using an FITC-coupled CD30 antibody and FITC-specific antibodies conjugated to superparamagnetic microbeads, or by CD30-specific antibodies directly conjugated to microbeads. In PB of healthy donors, at most 0.2% CD30-expressing cells were detectable before enrichment. These cells were enriched by MACS to up to 30% (Fig. 1) . Flow cytometric analysis showed that CD30 is expressed on a subpopulation of CD4-or CD8-positive T cells, as well as on a fraction of CD19 ϩ B cells, which are all CD15-negative. CD30 expression was neither detected on CD16 ϩ natural killer cells or neutrophilic granulocytes, nor on CD15 ϩ eosinophilic granulocytes or CD14 ϩ monocytes (Fig.  1c) . In two cases, cells from PB were analyzed after lysis of erythrocytes. In these cell suspensions that contain Ͼ50% of CD15-positive granulocytes and monocytes, CD30͞CD15 double-positive cells were also not detected (data not shown).
CD30-positive cells were also enriched from two inflamed lymph nodes (Table 1 ). The enriched CD30-positive cells were small, CD15-negative and presumably represent activated T and B cells (data not shown). From a lymph node of a HDlp case with CD30-negative tumor cells, CD30-positive cells could be enriched to a frequency of 41%. These cells were relatively small, mononucleated and CD15 Ϫ (Fig. 2) .
Isolation and Phenotypic Characterization of CD30-Positive Cells from Cases of Classical HD. In eight cases of classical HD, CD30-positive cells were enriched from lymph nodes from Ͻ0.1-0.7% to more than 50% (Table 1, Fig. 3) , with recoveries of up to 40-70%. An immunohistochemical staining of CD30 on cells enriched from a HDmc lymph node is shown in Fig. 4 . In two cases, CD30 ϩ cells were enriched from bone marrow of patients suffering from HDns (Table 1) . From one patient, CD30-positive cells were isolated from pericardial and pleural effusion. Fig. 3 exemplifies the separation of CD30-positive cells from an affected lymph node (HDns). In this case, as in about half of the cases of classical HD analyzed, two populations of CD30-positive cells were enriched, one brightly stained and the other rather dim. Analysis of the scatter characteristics by electronic gating of these two populations revealed that only the brightly stained population consists of large and granulated cells, whereas the more weakly stained cells are small and not granulated (Fig. 3) . Because Hodgkin and especially Reed͞Sternberg cells are very large and granulated cells, the scatter profile of the enriched cells indicates that the CD30-bright cells represent the H͞RS cell population. Furthermore, only these large and brightly stained cells could be counterstained with antibodies specific for CD15 (Fig. 3) . CD30-positive cells isolated from three HDns lymph nodes, from three HDmc lymph nodes, from a case of classical HD, lymphocyte rich, as well as from two bone marrow specimens of HDns cases all expressed CD15 ( Table   1) . One of four cases of HDmc was negative for CD15. However, in this case also the primary H͞RS cells in the tumor tissue did not express this antigen (not shown). Thus, in most cases of classical HD, large CD30 ϩ cells coexpressing CD15 could be isolated, likely representing H͞RS cells. The number of cells isolated in this way varied between Ϸ200 and 10 (Table 2 ). In comparison to the most homologous germ-line gene (WHG16G, ref. 29), the V H 3 gene rearrangement shows 25-point mutations (corresponding to a mutation frequency of 6.2% within the V H segment; sequences not shown). Two of the mutations are located near the 3Ј end of the sequence to which the V H 3 FRI primer hybridizes. These mutations likely prevented binding of the V H 3 FRI primer and thus explain why the rearrangement was not amplified when the V H FRI primer set was used. For case 6444, the three fragments of the p53 gene were successfully amplified from each of 10 cells analyzed, demonstrating a good quality of DNA in this case (not shown).
Taken together, in both cases in which a clonal Ig gene rearrangement was identified in H͞RS cells isolated from tissue sections, the same clonal rearrangement (and no others) could also be repeatedly amplified from MACS-purified H͞RS cells. . 11) , the molecular basis of the specific physiological properties of H͞RS cells is unresolved. A prerequisite for further studies in this direction would be the isolation of populations of viable H͞RS cells, if one does not want to resort to the analysis of H͞RS cell-derived cell lines. Here we report successful purification of H͞RS cells by high-gradient magnetic cell sorting on the basis of CD30 expression. We chose this antigen because it is expressed on H͞RS cells of nearly all cases of the most common subtypes of HD (HDns and HDmc) (9, 30) . Compared with other methods, MACS has been very efficient in the isolation of large and fragile cells, e.g., megakaryocytes (24) .
Magnetic Isolation of CD30 ؉ Cells. Because CD30 is also expressed on other subsets of lymphoid cells, such cells might be copurified together with the H͞RS cells. To characterize CD30-positive non-H͞RS cells we first analyzed PB and lymph nodes not affected by classical HD. Moreover, we assessed whether additional characteristics of H͞RS cells, namely their large cell size and expression of CD15, represent useful markers to discriminate H͞RS cells from other CD30-expressing cells. In PB, subpopulations of CD4 or CD8-positive T cells and CD19 ϩ B cells were found to express CD30, in accordance with the literature (28) . These cells had the size of small lymphocytes and were CD15-negative. On the other hand, among CD15-positive PB cells (i.e., neutrophilic and eosinophilic granulocytes), no CD30-positive cells were detectable. Also from inflamed lymph nodes or a lymph node affected by HDlp no large CD30-positive cells coexpressing CD15 could be enriched. Thus, in tissues not affected by classical HD, no CD15͞CD30 double-positive large cells were detectable.
In most cases of classical HD, the enriched large CD30-positive cells could also be stained with antibodies specific for CD15, strongly supporting that these cells represent the H͞RS cells (Table 1) . Only in one of the cases analyzed for CD15 expression, the isolated large CD30 ϩ cells were CD15-negative. In this case also the H͞RS cells in the tumor tissue lack CD15 expression. In instances, in which CD30-dim cells were coenriched with CD30-bright cells, the former could be clearly discriminated from the latter by their smaller size as well as the lack of CD15 expression. It should be possible to separate the CD30 ϩ non-H͞RS cells from the H͞RS cells by performing a second round of MACS separation using CD15 Microboeads after cleaving off the Multisortbeads from the first round of enrichment.
Taken together, by high gradient magnetic cell sorting using anti-CD30 antibodies, CD30͞CD15-double positive cells with large forward and side scatter characteristics were enriched from classical HD-infiltrated biopsy specimens. The morphology and phenotype of these cells, and the finding that cells with these features could not be enriched from various other tissues strongly indicates that the enriched cells represent the H͞RS tumor cells. (Table 2 ). Although our failure to amplify clonal Ig gene rearrangements from all CD30-positive cells picked from cytospins is likely due to technical problems (like insufficient DNA quality especially in case 6104, see above), we cannot rule out that some of the isolated cells were not H͞RS cells. However, the isolation of the tumor-specific clonal Ig Three different primer sets were used, as indicated: (i) six VH and four V family-specific primers hybridizing to sequences within FRI (VH, VFRI), (ii) The same six VH primers together with eight V family-specific FRI primers (VH, V FRI), and (iii) five VH leader family-specific primers (VH). Controls consisted of B and T cells micromanipulated on the same day from neighboring sections or independent cytospins. In one experiment, CD30-negative cells were micromanipulated as control from the same cytospin that was used for the isolation of HRS cells. Neg. controls consist of micromanipulated T cells and aliquots of the buffer covering the sections or cytospins. Repeated rearrangements indicates clonally related rearrangements; unique rearrangements are rearrangements obtained only once. The three B cell samples of the second experiment of case 6104 each contained two B cells. (31) . However, in the two cases analyzed in the present study, only the clonal Ig gene rearrangements carried by H͞RS cells micromanipulated from tissue sections were detected in H͞RS cells isolated from cell suspensions of the same lymph nodes after MACS-enrichment. This further supports the previous conclusion that within a given lymph node the H͞RS cells belong to a single clone (13) .
Perspectives. Enrichment of H͞RS cells by MACS will allow one not only to monitor the outcome of disease therapy, but also to increase the sensitivity for detection of minimal residual disease. The limit of detection in common PCR protocols is about 1 target cell in 10 5 cells (32) . Assuming that an approximate 100-fold enrichment of H͞RS cells as described here is feasible also when the frequency of these cells in the biopsy material is much lower, it should be possible to detect H͞RS cells that are present in a biopsy specimen at a frequency below 1 in 10 6 cells. Moreover, viable H͞RS cells can be studies in vitro in a variety of ways. Little is known about the molecular basis of H͞RS cell survival in vivo. Nguyen et al. (33) reported the expression of CD95 on H͞RS cells as well as high production of bcl-2 protein, speculating that the latter could be responsible for the prevention of apoptosis induced via the former. Moreover, a recent study indicates that constitutive activity of NF-B-RelA is required for the survival of H͞RS cells (34) . With the use of ex vivo isolated, viable H͞RS cells the signals required to induce apoptosis in H͞RS cells can be investigated. This might lead to the development of therapeutic approaches for the elimination of these cells. The isolation of viable H͞RS cells will also enable one to analyze the gene expression pattern at the single cell level. Finally, the MACS technique may also be used for purging of residual H͞RS cells from stem cell preparations used for autologous transplantations.
